Research Paper Volume 16, Issue 8 pp 6954—6989
Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification
Figure 8. The relationship between LAPTM4A expression and immunotherapy. (A) LAPTM4A differential expression status of the immune checkpoint genes under the high and low expression groups. (B) The correlation between LAPTM4A and the immune checkpoint genes. (C) The TIDE score of the LAPTM4A.